The Entero Healthcare Solutions IPO subscription period ran from February 9 to February 13, securing ₹716 crore from 25 anchor investors. Its listing date is scheduled for February 16, following the finalization of the IPO allotment process on February 14. The subscription status on the third day stood at 1.53 times, indicating a lukewarm response from both retail and non-institutional investors throughout the three days. As of today, the Entero Healthcare Solutions IPO Grey Market Premium (GMP) is +2, implying a ₹2 premium in the grey market, according to investorgain.com. This suggests a potential listing price of ₹1,260 per share, representing a slight increase of 0.16% from the IPO price of ₹1,258. Considering the GMP trend over the last 14 sessions, the current +2 GMP indicates a relatively modest premium compared to the highest observed GMP of ₹125 and the lowest of ₹0, as per investorgain.com. The 'Grey Market Premium' serves as an indicator of investor willingness to pay more than the issue price for shares.